These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23903473)

  • 1. TB care poses challenges, opportunities.
    Traynor K
    Am J Health Syst Pharm; 2013 Aug; 70(16):1366, 1370. PubMed ID: 23903473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Latent tuberculosis: chemoprophylactic coverage of household contacts in Peru].
    Maquera-Afaray J
    Rev Peru Med Exp Salud Publica; 2010 Jun; 27(2):302; author reply 303. PubMed ID: 21072488
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and implementation of a cohort review for latent TB infection.
    Mancuso JD; Aaron CL
    Chest; 2015 Jan; 147(1):e25-e26. PubMed ID: 25560872
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area.
    Rosales-Klintz S; Bruchfeld J; Haas W; Heldal E; Houben RMGJ; van Kessel F; Mandelbaum M; Matteelli A; Migliori GB; Oordt-Speets A; Solovic I; Vašáková M; Verver S; de Vlas SJ; Vonk Noordegraaf-Schouten MJM; de Vries G; Zenner D; van der Werf MJ
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30655449
    [No Abstract]   [Full Text] [Related]  

  • 5. Twelve-dose drug regimen now also an option for preventing tuberculosis in children and adolescents.
    Marais BJ
    JAMA Pediatr; 2015 Mar; 169(3):208-10. PubMed ID: 25581905
    [No Abstract]   [Full Text] [Related]  

  • 6. From latent to patent: rethinking prediction of tuberculosis.
    Cobelens F; Kik S; Esmail H; Cirillo DM; Lienhardt C; Matteelli A
    Lancet Respir Med; 2017 Apr; 5(4):243-244. PubMed ID: 28017341
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Is it safe?' Safety is a process, not a question.
    Shear NH
    Br J Dermatol; 2012 Nov; 167(5):968-9. PubMed ID: 23106352
    [No Abstract]   [Full Text] [Related]  

  • 8. Pasting together the preventive therapy puzzle.
    Skinner D; Mandalakas AM
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):175-7. PubMed ID: 23211672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D supplementation as a control program against latent tuberculosis infection in Korean high school students.
    Kim EH; Bae JM
    Epidemiol Health; 2018; 40():e2018035. PubMed ID: 30056639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive therapy for latent tuberculosis infection-the promise and the challenges.
    Fox GJ; Dobler CC; Marais BJ; Denholm JT
    Int J Infect Dis; 2017 Mar; 56():68-76. PubMed ID: 27872018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand.
    Tanvejsilp P; Pullenayegum E; Loeb M; Dushoff J; Xie F
    J Clin Pharm Ther; 2017 Jun; 42(3):337-344. PubMed ID: 28317143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contact tracing and prophylaxis of tuberculosis].
    Seersholm N; Wilcke T
    Ugeskr Laeger; 2011 Mar; 173(12):883-6. PubMed ID: 21419057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area.
    Moon HH; Park SY; Kim JM; Park JB; Kwon CHD; Peck KR; Kim SJ; Lee SK; Joh JW
    Ann Transplant; 2017 Jun; 22():338-345. PubMed ID: 28579606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial T-SPOT.TB and quantiFERON-TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection.
    Chiappini E; Bonsignori F; Mangone G; Galli L; Mazzantini R; Sollai S; Azzari C; de Martino M
    Pediatr Infect Dis J; 2012 Sep; 31(9):974-7. PubMed ID: 22572749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?
    Abud-Mendoza C; Martínez-Martínez MU; DE Jesús Macías-Mendoza J; Magaña-Aquino M
    J Rheumatol; 2010 Mar; 37(3):672-3; author reply 673. PubMed ID: 20197567
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Carter KL; Gabrellas AD; Shah S; Garland JM
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):432-437. PubMed ID: 28284259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Australia eliminate TB? Modelling immigration strategies for reaching MDG targets in a low-transmission setting.
    Denholm JT; McBryde ES
    Aust N Z J Public Health; 2014 Feb; 38(1):78-82. PubMed ID: 24494951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.